Eosinophilic peritonitis responding to treatment with glycyrrhizin.
A 63-year-old man with diabetes mellitus for 15 years was admitted to our hospital in 1990 because of end-stage renal failure. Five days after beginning continuous ambulatory peritoneal dialysis (CAPD) he developed an eosinophilic peritonitis (EP). With protein loss in the dialysate and a decreased serum albumin level, the patient developed ankle edema. The patient was treated with glycyrrhizin, and his EP resolved. It is suggested that an allergic background may play an important role in the development of EP in patients on CAPD.
Takeda
H
H
Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Ohta
K
K
Niki
H
H
Matsumoto
Y
Y
Tanaka
K
K
Machimura
H
H
Yagame
M
M
Inoue
W
W
Endoh
M
M
Kaneshige
H
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D004802:Eosinophilia / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006034:Glycyrrhetinic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019695:Glycyrrhizic Acid; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007073:Immunoglobulin E; D019695:Glycyrrhizic Acid; D006034:Glycyrrhetinic Acid